Vimarsana
Biggest News Aggregation in the World

Year Disease News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Year Disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Year Disease Today - Breaking & Trending Today

Wake Forest, Vanderbilt medical schools granted $3.2M for computer development for ear disease - Vimarsana News

Wake Forest, Vanderbilt medical schools granted $3.2M for computer development for ear disease

Researchers at the Wake Forest University of Medicine and Vanderbilt University Medical Center have been given a $3.2 million grant to develop computer-based approaches to ear disease diagnosis.

Source: yahoo.com
5 Lifestyle Habits To Keep Your Ear, Nose and Throat Healthy - Vimarsana News

5 Lifestyle Habits To Keep Your Ear, Nose and Throat Healthy

Taking care of our ear, nose, and throat is essential for our overall health. In this article, Dr. Shama tells us about 5 good lifestyle habits that will be beneficial in keeping our Ear, Nose and Throat clean and healthy. Dr. Shama also warns about bad unhygienic practices that can damage ENT Health severely. Let us know what are those healthy habits., Health News, Times Now

What is Tinnitus? All you need to know about the health condition that could affect your ear - Vimarsana News

What is Tinnitus? All you need to know about the health condition that could affect your ear

Dr Prateek Nayak, Consultant, and ENT Surgery, at Aster CMI Hospital, Bangalore, talks to IANSlife about one of the most frequent chronic health conditions.

Phase 2 | Benzinga - Vimarsana News

Phase 2 | Benzinga

The strongest catalysts for a pharma stock are the various milestones on the road to FDA approval for new drugs. For new investors, they’ll often see a stock rise astronomically, but, when they go to make sense of the reasons for the jump, they’re greeted with unfamiliar acronyms. Let... Read More...

Phase 3 | Benzinga - Vimarsana News

Phase 3 | Benzinga

BioXcel Therapeutics Inc (NASDAQ: BTAI) plans to finalize study design, dosing, and endpoints for its BXCL501 Phase 3 program in dementia-related agitation. The end of the Phase 2 meeting with the FDA is scheduled in Q2 2021. BXCL501 is an orally dissolving thin film formulation of... Read More...